All our lecturers have different academic profiles. Making contact with them and joining discussions is a unique feature of the Hessen International Summer University.

Prof. David Bardey

David Bardey is professor at the University of Los Andes (Bogota, Colombia) in the Department of Economics and is visiting fellow at Toulouse School of Economics. David Bardey's research agenda is mainly in health economics. More precisely, he applies contract theory, regulation and industrial organization theories to health economics. He has several publications dealing with drugs price regulation published in top field journals (e.g. Journal of Public Economics, Journal of Health Economics). He also works on genetic testing, personalized medicine and the consequences of this ongoing "revolution" on health insurance market.

Heléne Combrinck

Heléne Combrinck is an Associate Professor at the Faculty of Law, North-West University, South Africa. She previously worked as a senior researcher at the Centre for Disability Law and Policy, University of the Western Cape, Cape Town, which was preceded by a number of years as the project coordinator of the Gender Project at the (then) Community Law Centre, also at the University of the Western Cape. Her publications focus on disability rights as well as gender equality (with an emphasis on gender-based violence). From 2016 to 2017, she was a member of the task force convened by the International Bar Association’s Human Rights Institute to consider the rights of persons with albinism. Current research interests include the rights of persons with psychosocial disabilities and the development of disability rights in Africa.

Nils Dudenhoefer

Nils Dudenhoefer is Health Economist and is working at the Team of Business Exploration at Fresenius Medical Care. He completed his undergraduate Economics at Justus-Liebig University Giessen, followed by his post-graduate studies at both University of Wisconsin Milwaukee and Justus-Liebig University Giessen where he scientifically supported health economic benefit analysis in Pharmacoeconomics. Afterwards, he started his career as a M&A and Restructuration Consultant where he earned his first experiences in Life Science Industry. After a successful M&A deal Nils switched from consultancy directly to MedTech Industry where he worked on integration processes as well as in business development topics.

Currently, he is a Health Economics Manager at Fresenius Medical Care Business Exploration with a specific focus on lung and heart diseases. In this role, he elaborates on key issues for the future like the urgent demand for transplants and possible solutions to provide an unlimited supply of organs.

Dr. Bolko Ehlgen, LL.M. (Pennsylvania)

Bolko is an attorney specializing in intellectual property law, mainly patent litigation. He is qualified in Germany and the State of New York and works as a Managing Associate in the Frankfurt office of international law firm Linklaters LLP. He is mostly involved in patent cases from the health care and high tech sectors, in particular cross-border cases. Bolko has been specializing in intellectual property law since university and through the stages of his legal training has worked for the intellectual property practices of various international law firms. Bolko teaches classes in intellectual property law and general law school curriculum and regularly publishes articles on patent law.

Bolko studied law at the Universities of Heidelberg and Cologne. He wrote his Ph.D. thesis on the theory of causation in tort law, focussing on medical and legal malpractice. He obtained a Master's degree (LL.M.) from the University of Pennsylvania Law School in Philadelphia, USA

Prof. Dr. med. Bernd Griewing

Prof. Dr. med. Bernd Griewing received his MD degree from the University of Muenster. He is holding a professorship for neurology at the Ernst-Moritz-Arndt-University Greifswald. From 1998 till 2015 he was chief physician at the Neurologische Klinik Gmbh of Bad Neustadt.  Since 2002 he has run the Neurologische Klinik GmbH as medical director. Prof. Griewing was appointed to the executive board of RHOEN-KLNINIKUM AG as chief medical officer on January 1st 2016. He led the division patient safety, quality management and hygiene, the division medical process management and the division network medicine and innovation. He is also a member of various boards, for example the Muench foundation or the centre of telemedicine Bad Kissingen.

Dr. Michael Knipper

Michael Knipper is a research assistant at the institute for the history of medicine at the JLU Giessen, working group culture, migration and global health as well as coordinator of the “Schwerpunktcurriculum Global Health” of the faculty of medicine at the JLU Giessen. In 2014 Knipper got awarded the Ars-legendi price in medicine, since 2015 he is associated with the Research Program on Human Rights and Global Health of the University of Connecticut as an external member. Knipper studied medicine in Bonn/Germany and Oviedo/Spain (until 1996), after several years of medical practice (paediatrics, tropical medicine, until 2002) and after a medical-ethnologic research visit in the Amazon lowland of Ecuador (1997-1999) he changed over to the the institute for the history of medicine at the JLU Giessen. Since then his centers of interest in research and teaching have been History of medicine and medical ethnology, with special focus on medical pluralism and intercultural aspects of medicine, as well as global health, migration and the “human right to health”. Together with C. Mews (UKE Hamburg) he has the leadership of the committee for "Interkulturelle Kompetenz" Global Health of the German society for medical education (GMA). Currently Knipper works - among others - for MPG Brussels and the International Organization for Migration (IOM, Brussels) and for the "Health Strand" (sub-report on topics regarding health) issued by the Migrant Integration Policy Index (MIPEX).

Dr. Daniel Kuhn

Daniel Kuhn is currently working as a computational chemist and discovery project leader at Merck in Darmstadt, Germany. He obtained his PhD from Philipps-University, Marburg in computational chemistry working with Gerhard Klebe on the classification of protein binding sites. In 2004 he joined Boehringer Ingelheim in Vienna as a computational chemist working in oncology research. In 2010 he joined Merck as senior scientist contributing to projects in early and late drug discovery stages. He is also leading a lead optimization project towards preclinical development. His research interests include protein kinase drug discovery, structure-based design and knowledge-driven approaches to hit identification and lead-optimization.

Dr. Jörg Mahlich

Jörg Mahlich is head of Health Economics and Outcomes Research at Janssen pharmaceutical companies of Johnson and Johnson in Germany. In addition, he is lecturer of Health Economics at the Economics Department of the University of Vienna and research affiliate at the Düsseldorf Institute for Competition Economics (DICE) of the University of Düsseldorf, Germany.  Previous to that, he held different positions in industry and consulting in Austria, Germany, and Japan. He is interested in global pharmaceutical economics and policy. Jörg graduated in economics from the University of Kiel, Germany and holds a doctoral degree in economics from the University of Vienna, Austria.

Prof. Dr. Jürgen Meckl

Jürgen Meckl is Professor of International Economics at the University of Giessen and research fellow of the Institute for the Study of Labor, Bonn. He conducted his studies in economics at the University of Regensburg (diploma) and at the University of Konstanz (PhD and habilitation). He was visiting professor at the University of Wisconsin/Milwaukee, and at the University of Nottingham, among other universities. He was Dean of the Faculty of Economics and Business Studies in Giessen and is the coordinator of the Milwaukee-Giessen student exchange program. His research interests are in the fields of international trade, human-capital accumulation and economic growth, macroeconomics of structural change and labor economics.

Prof. Meckl has published several articles in leading academic journals of his field (e.g. American Economic Review, Economic Journal, Economic Theory). He has been awarded various prizes for his research and for his excellence in teaching (Lehrpreis des Landes Baden Württemberg, 1999).

Prof. Dr. Markus Meyer

Professor Markus Meyer is chief executive officer of a consulting firm, specializing in development of medical drug candidates. Prior, he was Senior Vice President & Chief Medical Officer (CMO) of Cardiorentis, a Swiss biotech company. As medical doctor, Professor Meyer combines the understanding of both the pathophysiology of diseases and of the mechanisms of actions of drugs to potentially treat these diseases. Over two decades of medical research, Professor Meyer gained his knowledge through his scientific and hands-on experience as a biotech entrepreneur. He co-founded biotech companies, one of them was CardioPep Pharma GmbH in Hannover, Germany, which was acquired by Cardiorentis AG. Professor Meyer received his M.D. from Heidelberg Medical School. During his studies, he also stayed at Universidad de Tucuman (Argentina) and at University of Illinois Chicago (USA). For his science and entrepreneurship, Professor Meyer received multiple awards and was appointed as adjunct Professor at Hannover Medical School (Germany) and Jakarta Medical School (Indonesia).

Dr. Christian Obermeier

Christian Obermeier is a postdoc working at the Insitute for Plant Breeding at Justus Liebig University Giessen. He graduated in biology at the Technical University in Braunschweig and has been working at the U.S. Department of Agriculture as well as at the Horticulture Research International, UK on the molecular characterization of plant virus diseases and plant-pathogen interaction using biotechnological approaches.

In Giessen he is studying gene expression and disease resistance in oilseed rape using high-throughput metabolomic and next generation sequencing-based transcriptome, genome and marker analysis techniques.

Dr. Arno Risse, LL.M. (Auckland)

Arno is a German lawyer and bar-certified specialist attorney for intellectual property law specialized on patent litigation. He is a Counsel with the IP specialized law firm Arnold Ruess in Düsseldorf. Before joining the Arnold Ruess team, he was working from 2010 to 2015 as an Associate and Principal Associate in the intellectual property and information technology practice group of Freshfields Bruckhaus Deringer. Arno teaches European Patent Law at the International Summer University Giessen (since 2015) and speaks at national and international patent law conferences. 

Arno graduated from the Westfälische Wilhelms-Universität in Münster and holds a Master's degree in commercial law (LL.M.) from the University of Auckland, New Zealand. He published a Ph.D. thesis on contract law. 

Prof. Dr. Monika Schuhmacher

Monika Schuhmacher is Professor of Technology, Innovation and Entrepreneurship at the University of Giessen. She is also Director of the Entrepreneurship Cluster Central Hesse at the University of Giessen. In the past, Monika Schuhmacher taught at the University of Mannheim, Mannheim Business School, Copenhagen Business School (Denmark) and the ESSEC Graduate School (France). Monika Schuhmacher conducted her studies at the University of Mannheim (diploma, PhD and habilation) and the University of North Carolina, Greensboro (M.B.A.).Her research interests are in the fields of technology and innovation management and -marketing, open innovation, reverse innovation, business model innovation, internet of things, and entrepreneurial marketing. Her teaching focus is primarily located in the areas of strategic technology and innovation management, innovation marketing, entrepreneurship, marketing management and global marketing. Prof. Schuhmacher has published articles in the International Journal of Research in Marketing, Journal of Product Innovation Management or Creativity & Innovation Management.

Dr. Janina Trauth

Dr. Trauth is a Senior Physician for Infectious Diseases at the “Department of Internal Medicine, Pulmonary Medicine and Critical Care Medicine and Infectious Diseases” of the University Hospital of Giessen and Marburg (UKGM). Dr. Trauth specializes in the treatment and management of patients suffering from HIV, Hepatitis B/C/D and other infectious diseases. Dr. Trauth is a specialist for ART therapy, including 2nd line/rescue therapy and management of side effects. After her studies in Giessen and Madrid, Dr. Trauth received her medical license and earned her doctoral degree with distinction (magna cum laude). She holds board certifications in Infectious Diseases, Emergency Medicine and Internal Medicine. Besides her work as a physician, Dr. Trauth teaches and supervises medical students. She is principal investigator and investigator in various clinical trials on infectious diseases (Phase II-IV).

Dr. Jörk Zwicker

Dr. Jörk Zwicker is partner of the partnership Zwicker Schnappauf & Partner (ZSP) Patentanwälte. Jörk studied chemistry at the Technical University (TU) Berlin and biology at the Massachusetts Institute of Technology (MIT) in Boston. He concluded his PhD at the Philipps-University Marburg at the Institute for Molecular and Tumor Biology (IMT) followed by postdoctoral work in the Department of Molecular & Cell Biology at the University of California, Berkeley (UCB). Since 1999 Jörk works in the field of intellectual property rights and advises German and international biotech and pharmaceutical clients in developing, defending and enforcing their intellectual property portfolios, which includes patent disputes that relate to block buster biopharmaceuticals.